SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-23-002583
Filing Date
2023-03-07
Accepted
2023-03-07 17:57:37
Documents
2
Period of Report
2023-03-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1684
2 POWER OF ATTORNEY fox-poa.txt EX-99 2007
  Complete submission text file 0001562180-23-002583.txt   5046
Mailing Address C/O MYOKARDIA, INC. 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Fox Jonathan C (Reporting) CIK: 0001655016 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40236 | Film No.: 23714159

Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Issuer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations